14-day Premium Trial Subscription Try For FreeTry Free
NASDAQ:OCRX
Delisted

Ocera Therapeutics Fund Predictions

$1.79
+0 (+0%)
At Close: Jan 16, 2018
Currently predicting for Thu, 9 May 2024

Trading levels for OCRX

Fibonacci Support & Resistance Levels

Level Price
Resistance R3 1.79 .
R2 1.79 .
R1 1.79 .
Current price: 1.79
Support S1 1.79 .
S2 1.79 .
S3 1.79 .

Accumulated Volume Support & Resistance Levels

Level Price
Resistance R3 0 .
R2 0 .
R1 0 .
Current price 1.79
Support S1 1.72 -3.91%
S2 1.70 -5.03%
S3 1.69 -5.59%

OCRX Predictions History

6 years ago
JuanC Villegas predicted that OCRX for 2017-11-14 is going $1.70 (-2.86%)

6 years ago
JuanC Villegas predicted that OCRX for 2017-11-13 is going $1.70 (0.00%)

6 years ago
JS predicted that OCRX for 2017-11-13 is going $1.71 (0.59%)

6 years ago
Mike.Miller.7037 predicted that OCRX for 2017-07-25 is going $1.24 (-2.36%)

Rank:

6 years ago
Mike.Miller.7037 predicted that OCRX for 2017-05-17 is going $1.32 (8.20%)

Rank:

7 years ago
Itthiched.Kriengyuttapoom.5680 predicted that OCRX for 2017-04-18 is going $0.340 (-76.55%)

Rank:

7 years ago
Ni.Wr.3109 predicted that OCRX for 2017-03-27 is going $1.24 (-3.88%)

Rank:

7 years ago
JS predicted that OCRX for 2017-03-27 is going $1.25 (-3.10%)

7 years ago
Jac1970 predicted that OCRX for 2017-03-13 is going $1.90 (35.71%)

Rank:

7 years ago
JS predicted that OCRX for 2017-03-13 is going $1.23 (-12.14%)

Click to get the best stock tips daily for free!

About Ocera Therapeutics

Ocera Therapeutics, Inc. operates as a clinical stage biopharmaceutical company. It focuses on the development and commercialization of OCR-002, which is in Phase IIb trials for the treatment of hyperammonemia and hepatic encephalopathy in patients with liver cirrhosis, acute liver injury, and acute liver failure, as well as in the areas of unmet medical need. The company is headquartered in Palo Alto, California.... OCRX Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT